San Francisco, CA – May 2026 – Remepy, a burgeoning health technology startup at the vanguard of integrating pharmaceutical and…
Read More
Scientists Uncover Bacterial Secret to Manufacturing Diverse Cancer Drugs
In a groundbreaking discovery that promises to accelerate the development of novel cancer therapies, scientists have elucidated the intricate molecular…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
More than 5,000 potential treatments for rare diseases are currently languishing on pharmaceutical company shelves, representing a vast, untapped reservoir…
Read More
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
A new era in therapeutic innovation is dawning, marked by the successful Phase IIa clinical trial results for Hybridopa, an…
Read More
GLP-1R Weight Loss Drugs May Alleviate Depression Through Gut Microbiome-Endocannabinoid-Brain Axis
Emerging evidence has consistently suggested that glucagon-like peptide-1 receptor (GLP-1R) weight loss drugs, initially developed for metabolic conditions, may offer…
Read More
Beyond PD-1: The Drugs Reshaping Cancer Treatment at ASCO 2026
The biotech sector is experiencing a robust resurgence, marked by significant investment, strategic mergers and acquisitions, and groundbreaking clinical advancements,…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
More than 5,000 potentially life-changing treatments for rare diseases are currently languishing on the shelves of pharmaceutical companies, dormant and…
Read More
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…
Read More
Beyond PD-1: The drugs reshaping cancer treatment at ASCO 2026
The global biotechnology sector is experiencing a significant resurgence, marked by robust investment, strategic mergers and acquisitions, and groundbreaking scientific…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
Across the global pharmaceutical landscape, an estimated 5,000 potential treatments for rare diseases are currently languishing on corporate shelves, representing…
Read MoreYOU MAY HAVE MISSED
